ELAVL3 stabilizes MYCN mRNA and provides a therapeutic target in neuroendocrine prostate cancer [LNCaP/AR/shTP53/shRB1]
Ontology highlight
ABSTRACT: ELAVL3 stabilizes MYCN mRNA and provides a therapeutic target in neuroendocrine prostate cancer [LNCaP/AR/shTP53/shRB1]
PROVIDER: PRJNA934548 | ENA |
REPOSITORIES: ENA
ACCESS DATA